Skip to main content

ETF comparison

IXJ vs XLV

Both Healthcare.

iShares Global Healthcare ETF · State Street Health Care Select Sector SPDR ETF

Holdings overlap

Weighted by ISIN/CUSIP
70.9 %

60 positions appear in both funds. Buying equal dollars of IXJ and XLV would leave roughly 70.9% of each dollar exposed to the same underlying securities.

IXJ unmatched 28.6% Shared 70.9% XLV unmatched 28.8%

Unmatched is the part of a fund's weight the other fund doesn't match: names only it holds, plus any extra weight it puts in names both funds hold.

In IXJ only
50 positions
Shared
60 positions
In XLV only
0 positions

Side by side

IXJ

iShares Global Healthcare ETF

iShares · Healthcare

69 composite / 100
Expense ratio
0.38%
Net assets
$4.32B
TTM yield
1.32%
Top-10 conc.
47.8%
XLV

State Street Health Care Select Sector SPDR ETF

State Street · Healthcare

82 composite / 100
Expense ratio
0.080%
Net assets
$43.39B
TTM yield
1.42%
Top-10 conc.
61.5%

Sub-score comparison

62
Cost
92
83
Tax efficiency
83
84
Liquidity
100
46
Concentration
26
—
Tracking quality
—
IXJ sub-score XLV

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

XLV is 30 bps cheaper than IXJ. On a $100,000 position that's about $300/yr more in fees for IXJ.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with IXJ vs XLV.

Top shared holdings

60 shared in total
# Holding In IXJ In XLV Overlap
1 ELI LILLY AND COMPANY 10.93% 16.51% 10.93%
2 JOHNSON & JOHNSON 7.04% 10.64% 7.04%
3 ABBVIE INC. 5.12% 7.74% 5.12%
4 UNITEDHEALTH GROUP INCORPORATED 4.40% 6.57% 4.40%
5 MERCK & CO., INC. 4.12% 5.52% 4.12%
6 AMGEN INC. 2.54% 3.40% 2.54%
7 THERMO FISHER SCIENTIFIC INCORPORATED 2.42% 3.24% 2.42%
8 ABBOTT LABORATORIES 2.05% 2.75% 2.05%
9 GILEAD SCIENCES, INC. 2.04% 2.73% 2.04%
10 INTUITIVE SURGICAL, INC. 1.83% 2.45% 1.83%
11 PFIZER INC. 1.78% 2.39% 1.78%
12 CVS HEALTH CORPORATION 1.71% 2.30% 1.71%

Only in IXJ

50 total
  • ASTRAZENECA PLC 3.76%
  • Roche Holding AG 3.75%
  • Novartis AG 3.71%
  • NOVO NORDISK A/S 1.99%
  • GSK PLC 1.38%
  • SANOFI SA 1.18%
  • argenx SE 0.74%
  • ESSILORLUXOTTICA SA 0.71%
  • Bayer Aktiengesellschaft 0.71%
  • HOYA CORPORATION 0.70%

Only in XLV

0 total

Every XLV position is also held by IXJ.

Percentages are holdings overlap with the named fund.

Open IXJ or XLV at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.